Factor analysis reveals differences in brain metabolism in macaques with SIV/AIDS and those with SIV-induced

Margaret R Lentz1, Vallent Lee, Susan V Westmoreland

  • 1Department of Neuroradiology/A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA 02129, USA.

NMR in Biomedicine
|June 25, 2008
PubMed

Insights

Factor analysis of magnetic resonance spectroscopy (MRS) data revealed distinct metabolic patterns in SIV-infected macaques. These patterns help differentiate healthy animals from those with SIV/AIDS and identify disease severity, including encephalitis.

Area of Science:

  • Neuroscience
  • Metabolic Imaging
  • Primate Models

Background:

  • Metabolic processes in the HIV-infected brain are studied using Magnetic Resonance Spectroscopy (MRS).
  • Understanding inter-metabolite relationships in virus-induced central nervous system dysfunction remains unclear.

Purpose of the Study:

  • To identify patterns of metabolite distributions using factor analysis (FA) in healthy and SIV-infected macaques.
  • To correlate metabolic changes with disease progression and central nervous system dysfunction.

Main Methods:

  • Magnetic Resonance Spectroscopy (MRS) was employed on healthy and SIV-infected macaques.
  • Factor Analysis (FA) was used to analyze correlations among nine metabolites.
  • Statistical analysis identified key metabolic factors differentiating disease states.

Main Results:

  • FA identified three main factors summarizing metabolite correlations.
  • Factor 3 distinguished healthy animals from those with SIV/AIDS.
  • Factor 2 differentiated animals with encephalitis from those moribund with AIDS but without encephalitis, and identified disease severity.
  • Confirmed involvement of N-acetylaspartate and glutamate; detected novel changes in creatine and myo-inositol.

Conclusions:

  • Factor analysis provides a robust method for analyzing complex metabolic data in SIV infection.
  • Metabolic profiles identified by FA can serve as biomarkers for disease state and severity.
  • The N-acetylaspartate/creatine ratio may be a more sensitive marker for disease severity due to divergent metabolic pathways.

Related Concept Videos